期刊文献+

重症监护室患者血清降钙素原与CRP相关指标测定的临床意义 被引量:8

Clinical significance of determination of serum procalcitonin and CRP related indexes in ICU patients
下载PDF
导出
摘要 目的:探讨血清降钙素原监测在判断重症患者是否并发感染的的价值。方法收集重症监护病房(ICU)188例患者分为感染组和未感染组,同时监测血清 PCT、CRP、白细胞总数和中性粒细胞比值;感染组中41例患者连续1~6 d 动态测定 PCT及相关指标,并进行统计学分析。结果重症感染组(112例)和重症非感染组(76例)的年龄、PCT、CRP 比较差异有统计学意义;除感染组 PCT 和 CRP 相关性比较有统计学意义外,其他指标比较差异无统计学意义(P >0.05);感染者中出院组(32例)和死亡组(9例),第1、2天两者 PCT 值比较 P >0.05,第3~6天 PCT 值比较,差异有统计学意义(P <0.05)。结论血清 PCT 是判断重症患者感染与否的有效指标,独立并且明显优于传统的炎症指标,在重症患者中动态监测其水平对判断感染的控制情况具有一定价值。 Objective To explore the value of serum procalcitonin detection in judging whether severe patients complicate with infection.Methods 188 patients in the intensive care unit (ICU)were collected and divided into the infection and non-infection groups.The serum procalcitonin(PCT),C-reactive protein(CRP),total number of white blood cells(WBC)and neutrophile cell ratio were simultaneously monitored;41 cases in the infection group dynamically monitored PCT and related indicators for continuous 1-6 d and the statistical analysis was conducted.Results The age,PCT and CRP had statistically significant differences between the infection group(112 cases)and non-infection group(76 cases).Except the correlation of PCT and CRP in the infection group showing statistical significance,the comparison of the other indicators had no statistical differences.In the infectors,the PCT value comparison between on 1 d and 2 d in the hospital discharge group(32 cases)and the death group (9 cases)showed P 〉0.05,the PCT value comparison between on 3-6 d showed P 〈0.05.Conclusion Serum PCT is an effective indicator to judge whether se-vere infected patient has infection and is significantly superior to the traditional inflammatory indicators.Dynamically monitoring the PCT level in the critical patients has a certain value to judge the control situation of infection.
出处 《国际检验医学杂志》 CAS 2014年第14期1848-1850,共3页 International Journal of Laboratory Medicine
关键词 重症患者 PCT CRP 感染 critical patients PCT CRP infection
  • 相关文献

参考文献10

二级参考文献60

  • 1简序,王金和,程佩兰.C反应蛋白的临床研究进展[J].国际检验医学杂志,2004,26(5):471-473. 被引量:137
  • 2崔晓明.C-反应蛋白测定对小儿急性上呼吸道感染的临床价值[J].实用诊断与治疗杂志,2004,18(5):383-384. 被引量:26
  • 3宋秀琴,时兢,俞亚芬,穆会君.动态检测血清降钙素原水平对多发伤患者伤情判断的临床意义[J].中国急救医学,2004,24(7):488-489. 被引量:8
  • 4左震华,蔡少华,李洪霞,刘长庭,俞森洋.降钙素原对呼吸机相关性肺炎诊断及预后判断的临床意义[J].中华医院感染学杂志,2006,16(12):1353-1355. 被引量:34
  • 5Clark RS, Schiding JK, Kaczomwski SL, et al. Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models[ J]. J Neurotrauma, 1994,11 (5) :499-506.
  • 6Giulian D, Chen J, Ingeman JE, et al. The role of mononuelear phagocytes in wound healing after traumatic injury to adult mammalian brain[J]. J Neurosei, 1989,9(12) :4416-4429.
  • 7Keskil S, Baykaner MK, Ceviker N, et al. Head trauma and leueoeytosis[ J]. Aeta Neurochir(Wien) , 1994,131 (3-4) :211-214.
  • 8Biagas KV, Uhl MW, Schiding JK, et al. Assessment of posttraumatie polymorphonuclear leukocyte accumulation in rat brain using tissue myeloperoxidase assay and vinblastine treatment[ J]. J Neurotrauma, 1992,9(4) :363-371.
  • 9Hartl R, Medary MB, Ruge M, et al. Early white blood cell dynamics after traumatic brain injury:effects on the cerebral microcirculation[ J]. J Cereb Blood Flow Metab, 1997,17 ( 11 ) : 1210-1220.
  • 10[1]Dandona P.Nix D,Wilson MF,et al.Procalcitonin increase.Metab,1994.79(6):1605-1608

共引文献171

同被引文献82

  • 1杨永昌,王北宁.C反应蛋白的临床研究进展[J].中国误诊学杂志,2007,7(4):693-695. 被引量:56
  • 2Picadello C, Lazzeri C, Valente S, et al. Kinetics of procalcito- nin in cardiangenic shock and in septic shock. Preliminary data [J]. Acute Card Care,2010,12(3) :96-101.
  • 3Morgenthaler NG, Struck J, Chancerelle Y, et al. Production of procalcitonin in non-thyroidal tissue after LPS injection [ J ]. Horm Metab Res,2003,35 (5) :290-295.
  • 4Eisenhut M. A persistently elevated C-reactive protein level in pneumonia may indicate empyema E J 1. Crit Care,2008,12 ( 1 ) : 409.
  • 5Bouadma L, Luytc E, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial ):a multicentre randomised controled trial. Lancet,2010,375 (9713) :463-474.
  • 6Haubitz S, Mueller B, Schuetz P. Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies [ J]. Expert Rev Respir Med,2013,7 (2) : 145-157.
  • 7Stocker M, Fontana M, Helou S, et al. Use of procalcition in guided decision making to shorten antibiotic therapy in suspec- ted neonatal early onset sepsis:prospective randomized interven- tion trial [ J]. Neonatology ,2009,97 (2) : 165-174.
  • 8Li H X, Liu Z M, Zhao S J, et al. Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients[ J]. J Int Med Res ,2014,42 (4) : 1050-1059.
  • 9Hyucklee. Procalcitonin as a biomarker of infectious diseases [J]. Korean J intern Med,2012,28(3) :285-291.
  • 10Reinhart K, Bauer M, Riedemann NC, et al. New approaches to sepsis : molecular diagbistics and biomarkers [ J ]. Clin Microbiol Rev ,2012,25:609-634.

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部